Investigational Site Number : 528001

Amsterdam 1105 AZ

0 studies enrolling now · 5 studies all time

What they study most

Ankylosing Spondylitis, Hypercholesterolemia, Lymphoma, Neoplasm Malignant, Sphingomyelin Lipidosis

Studies at this site

• Efficacy, Safety, Pharmacodynamic, and Pharmacokinetics Study of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency — Completed
• Phase 1 Safety Testing of SAR405838 — Completed
• Dose Ranging Study to Evaluate the Efficacy and Safety of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis — Completed
• A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia — Completed
• Long-term Safety and Tolerability of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY Long Term) — Completed